← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Novartis Vaccines And Diagnostics, Inc.
Cambridge, MA
$51,562,616
Total funding
23
Grants
Funding over time
peak $9.4M · FY2005–13$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$51,562,616 · 23
By mechanism
P01$21,015,844 · 16
UC1$10,427,728 · 1
N01$10,246,748 · 3
U01$9,288,117 · 2
R21$584,179 · 1
Investigators at Novartis Vaccines And Diagnostics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of a SARS Coronavirus Vaccine$10,427,728
UC1 · FY2004 · AI
HIV VACCINE DESIGN &DEVELOPMENT TEAMS$7,545,418
N01 · FY2000 · AI
Targeting Neutralizing Epitopes in the HIV Envelope$4,688,092
P01 · FY2010 · AI
Targeting Neutralizing Epitopes in the HIV Envelope$4,519,452
P01 · FY2008 · AI
Targeting Neutralizing Epitopes in the HIV Envelope$4,260,986
P01 · FY2009 · AI
Targeting Neutralizing Epitopes in the HIV Envelope$4,056,563
P01 · FY2007 · AI
Targeting Neutralizing Epitopes in the HIV Envelope$3,734,382
P01 · FY2006 · AI
Multi-component HIV Vaccines Using Engineered Envelopes$2,407,540
P01 · FY2004 · AI
Multi-component HIV Vaccines Using Engineered Envelopes$2,306,242
P01 · FY2003 · AI
HIV Vaccine Design and Development Teams, Part A- Preventative Vaccines$2,186,845
N01 · FY2013 · AI
Novel Adjuvants/Delivery Systems for Biodefense Vaccines$2,035,822
U01 · FY2004 · AI
Multi-component HIV Vaccines Using Engineered Envelopes$1,894,091
P01 · FY2002 · AI
Evaluation of HIV-1 Vaccine Candidates in Macaca mulatta$1,659,714
P01 · FY2010 · AI
Novel Adjuvants/Delivery Systems for Biodefense Vaccines$1,624,853
U01 · FY2005 · AI
Evaluation of HIV-1 Vaccine Candidates in Macaca mulatta$1,571,377
P01 · FY2008 · AI
Evaluation of HIV-1 Vaccine Candidates in Macaca mulatta$1,505,898
P01 · FY2009 · AI
Evaluation of HIV-1 Vaccine Candidates in Macaca mulatta$1,105,275
P01 · FY2007 · AI
Development of Rapid Diagnostic Tests for Hantaviruses$1,074,529
U01 · FY2004 · AI
Development of Rapid Diagnostic Tests for Hantaviruses$1,060,253
U01 · FY2005 · AI
Novel Adjuvants/Delivery Systems for Biodefense Vaccines$1,019,625
U01 · FY2003 · AI